Announcements Trials
Browse Landscape

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Heart Diseases 3Vascular Diseases 2Small Cell Lung Carcinoma 2Cardiovascular Diseases 2Cardiotoxicity 2Triple Negative Breast Neoplasms 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Cancer Resectable 1Ovarian Carcinosarcoma 1Neoplasms, Second Primary 1Myelodysplastic Syndromes 1Metabolic Diseases 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Immune-related Adverse Event 1Hematologic Neoplasms 1Heart Failure 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1Carcinoma, Hepatocellular 1Cancer Therapy-related Cardiovascular Toxicity 1Breast Neoplasms 1Advanced Ovarian Cancer 1

Interventions

Exercise 4Cholecalciferol 4Nutrition Assessment 3Gonadotropin-Releasing Hormone 3Blood Pressure 3Atorvastatin 3palbociclib 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2acalabrutinib 2Vitamin E 2Social Determinants of Health 2Rosuvastatin Calcium 2Metformin 2Geritol 2Fish Oils 2Fatty Acids, Omega-3 2Ethanol 2Electrocardiography 2Educational Status 2Echocardiography 2Diet, Mediterranean 2Blood Specimen Collection 2Aspirin 2Antineoplastic Agents 2Absorptiometry, Photon 2zanubrutinib 1xinmailong 1ribociclib 1phosphoribosylformylglycinamidine synthetase 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Cardiovascular Diseases × Antineoplastic Agents × Clear all
NCT07621289 2026-06-02

EUCARTOXSCORES

University Hospital, Caen

Not yet recruiting
10,000 enrolled
Other hematologic neoplasm

Cardiovascular Diseases, Neoplasms, Hematologic Neoplasms

NCT06409481 2024-05-10

PARCA

The First Affiliated Hospital of Xinxiang Medical College

Unknown
800,000 enrolled

Cardiovascular Diseases, Heart Diseases, Neoplasms, Vascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡